{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-24-018934","form_type":"8-K","ticker":"CTNM","cik":"0001855175","company_name":"Contineum Therapeutics, Inc.","filed_at":"2024-05-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:20.887335+00:00","generated_at":"2026-06-01T07:15:00.140043+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Contineum Therapeutics adopts Executive Severance Plan for named executive officers","bullets":["CEO Carmine Stengone designated Tier 1 participant; CSO Lorrain, CFO Slover designated Tier 2 participants.","Non-CIC severance: 12 months base salary + pro-rata bonus; health coverage up to 12 months.","CIC severance: 150% (Tier1) or 100% (Tier2) of salary+bonus; equity acceleration; health to 18/12 mo.","Plan replaces prior severance agreements; participants must sign release and arbitration agreement.","Plan effective May 24; participation agreements executed May 28, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-24-018934","json":"https://secwatch.observer/filing/0001437749-24-018934.json","markdown":"https://secwatch.observer/filing/0001437749-24-018934.md","text":"https://secwatch.observer/filing/0001437749-24-018934.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1855175/000143774924018934/0001437749-24-018934-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1855175/000143774924018934/cont20240524_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:15:00.140043+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}